SiriusXT

About:

SiriusXT has developed and manufactures a soft x-ray microscope

Website: http://siriusxt.com/

Twitter/X: SiriusXT_Ltd

Top Investors: European Innovation Council, Enterprise Ireland, EASME - EU Executive Agency for SMEs, Horizon 2020, Act Venture Capital

Description:

SiriusXT has developed and manufactures a soft x-ray microscope (the SXT system), which is marketed primarily to researchers working in disease research and drug discovery. The core technology, underpinning the SiriusXT microscope is a vacuum-based laser-produced plasma (LPP) soft x-ray light source. Soft x-ray tomography is essentially a CT scan of the cell, and is critical to life scientists looking to image the 3D internal structure of an entire cell in its native fully hydrated state. The SXT system is used by disease researchers, pharmaceutical companies, bio-technologists and clinicians to aid the understanding of disease pathways, protein-drug interactions and bio-engineering processes. SiriusXT provides the first high-throughput, bench-top, SXT system in the world, capable of producing high resolution, full cell 3D tomographs in minutes.

Total Funding Amount:

$17.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dublin, Dublin, Ireland

Founded Date:

2015-01-01

Contact Email:

info(AT)siriusxt.ie

Founders:

Fergal O' Reilly, Kenneth Fahy, Paul Sheridan, Tony McEnroe

Number of Employees:

1-10

Last Funding Date:

2020-10-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai